Vascular Patches - Market Insights, Competitive Landscape, and Market Forecast - 2030

Vascular Patches Market by Material Type (Biologic Vascular Patches and Synthetic Vascular Patches), Application Type (Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, and Others), End-User (Hospital, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing instances of chronic cardiovascular conditions, rising product developmental activities globally

The vascular patches market is estimated to grow at a CAGR of 7.37% during the forecast period from 2024 to 2030. The vascular patches market is growing significantly due to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, coronary artery disease (CAD) with growing shift toward endovascular treatments, availability of a wide range of vascular patches, and innovative product developmental activities by leading companies that are expected to escalate the demand for vascular patches during the forecast period from 2024 to 2030.

Vascular Patches Market Dynamics:

As per data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to recent data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are living with CAD around the world. Vascular patches play a vital role in procedures like arterial repairs, endarterectomy, and aneurysm reconstruction, offering improved outcomes and minimizing complications, making them indispensable in contemporary cardiovascular treatments. Hence the market for the same is increasing.

Increased product developmental activities by market key players across the globe is further expected to drive the market growth for vascular patches. For example, in May 2024, the consortium of Teijin Limited, Fukui Tateami Co., Ltd., and Osaka Medical and Pharmaceutical University announced that, SYNFOLIUM(R) a novel cardiovascular surgical patch, designed with a knitted fabric composed of both bio-absorbable and non-absorbable yarns, coated with cross-linked gelatin was scheduled for manufacturing and distribution from June 2024.

Therefore, the factors stated above collectively will drive the overall vascular patches market during the forecast period from 2024 to 2030.

However, availability of alternative options, stringent regulatory approval process, and others may limit their end-user base, thus acting as key constraints limiting the growth of the vascular patches.

Vascular Patches Market Segment Analysis:

Vascular Patches Market by Material Type (Biologic Vascular Patches and Synthetic Vascular Patches), Application Type (Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, and Others), End-User (Hospital, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the material type segment of vascular patches, the biologic vascular patch category is expected to have a significant revenue share in the year 2023. The rapid growth of this product category is growing due to its superior biocompatibility, reduced immunogenicity, and enhanced long-term outcomes compared to synthetic alternatives.

Biologic patches, derived from materials like bovine pericardium or porcine-derived tissues, offer excellent tissue integration and remodeling properties, minimizing complications such as thrombosis, calcification, or infection. Their natural structure supports endothelialization, which is critical for vascular healing and maintaining patency in arterial and venous reconstructions.

Additionally, advancements in tissue processing techniques, such as decellularization and crosslinking, have improved the durability and safety profiles of biologic patches, making them more suitable for complex vascular procedures. With the increasing prevalence of vascular diseases and a growing preference for natural and less reactive implant materials, biologic vascular patches are becoming a preferred choice among surgeons, especially in applications requiring high performance and minimal complications.

Therefore, owing to all the above-mentioned factors, the demand for the biologic vascular patch category is expected to witness considerable growth eventually contributing to the overall growth of the vascular patches market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall vascular patches market:

Among all the regions, North America is expected to dominate the vascular patches market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. The increasing prevalence of cardiovascular conditions such as coronary artery disease (CAD), myocardial infarction, and peripheral artery disease (PAD), along with rising comorbidities like hypertension and hyperlipidemia, combined with significant advancements in product development and regulatory approvals, and the presence of well- established and sophisticated infrastructure is expected to drive the market for vascular patches during the forecast period from 2024 to 2030.

As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure, among others. Some of the key risk factors associated with heart diseases are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.

According to data from the Canadian Institute for Health Information (2024), it stated that in 2022, 2.4 million Canadians were affected by heart disease.

As per data from the American Heart Association, 2021, PAD affected about 8.5 million U.S. adults over the age of 40, in 2021. As per the same source, African Americans are more likely to screen positive for PAD than non-Hispanic adults.

Vascular patches are critical in surgical interventions, offering improved vessel repair, reduced complications, and enhanced long-term outcomes, thereby bolstering the market for same.

Rising product launches and commercialization agreements among key manufacturers and other companies are anticipated to boost the market. For instance, in June 2021, Axio Biosolutions announced FDA 510(k) clearance of its hemostatic product Axiostat Patch, which helps control moderate to severe bleeding in vascular procedures.

Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North American region in the vascular patches market.

Vascular Patches Market key players:

Some of the key market players operating in the vascular patches market include B. Braun Melsungen AG, Baxter, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates, Inc., CryoLife, Inc, Aziyo, Medtrade Products Ltd, Collagen Solutions Plc, FOC Medical S.A., Anteris, Medtronic, Labcor Laboratorios, BD, Johnson & Johnson Services, Inc., Axio Biosolutions, and others.

Recent Developmental Activities in the Vascular Patches Market:

• In August 2024, Haemonetics fully launched the Vascade MVP XL Vascular Closure System, featuring collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.
• In September 2021, Terumo Corporation announced the launch of global surgical graft study known as PANTHER, which is a prospective and retrospective study of a comprehensive range of knitted and woven surgical grafts and cardiovascular patches.

Key Takeaways from the Vascular Patches Market Report Study

• Market size analysis for current vascular patches market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the vascular patches market
• Various opportunities available for the other competitors in the vascular patches market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current vascular patches market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for vascular patches market growth in the coming future?

Target audience who can be benefited from this vascular patches Market Report Study

• Vascular patches product providers
• Research organizations and consulting companies
• Vascular patches-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in vascular patches
• Various end-users who want to know more about the vascular patches market and the latest developments in the vascular patches market

Frequently Asked Questions for the Vascular Patches Market:

1. What are vascular patches?

• The vascular patches, are the patches that are broadly used in blood vessel repair and reconstruction and when blood vessels are severely compromised in cardiovascular diseases, infection, and/or in transplantation. Patches are is characterized by excellent biocompatibility and proven long-term mechanical stability.

2. What is the market for vascular patches?

• The Vascular Patches market is estimated to grow at a CAGR of 7.37% during the forecast period from 2024 to 2030.

3. What are the drivers for the vascular patches market?

• The vascular patches market is growing significantly due to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, coronary artery disease (CAD) with growing shift toward endovascular treatments, availability of wide range of vascular patches, and innovative product developmental activities by leading companies that are expected to escalate the demand for vascular patches during the forecast period from 2024 to 2030.

4. Who are the key players operating in the vascular patches market?

• Some of the key market players operating in the vascular patches market include B. Braun Melsungen AG, Baxter, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates, Inc., CryoLife, Inc, Aziyo, Medtrade Products Ltd, Collagen Solutions Plc, FOC Medical S.A., Anteris, Medtronic, Labcor Laboratorios, BD, Johnson & Johnson Services, Inc., Axio Biosolutions, and others.

5. Which region has the highest share in the vascular patches market?

• Among all the regions, North America is estimated to hold a significant revenue share in the vascular patches market. The increasing prevalence of cardiovascular conditions such as coronary artery disease (CAD), myocardial infarction, and peripheral artery disease (PAD), along with rising comorbidities like hypertension and hyperlipidemia, combined with significant advancements in product development and regulatory approvals, and the presence of well- established and sophisticated infrastructure is expected to drive the market for vascular patches during the forecast period from 2024 to 2030.